
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Approach to minimal bright red blood per rectum in adults</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Approach to minimal bright red blood per rectum in adults</strong></summary>
            <div>
                <ul><li>Official reprint from UpToDate®.</li><li>Literature review current through: Sep 2025.</li><li>Topic last updated: Aug 26, 2025.</li><li>Target Audience: Physicians.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What percentage of minimal BRBPR cases are typically attributed to benign etiologies?</li><li>2. At what age does the incidence of colorectal cancer begin to significantly increase, making it a key factor in BRBPR evaluation?</li><li>3. What specific type of bleeding pattern is referred to as &#x27;outlet-type bleeding&#x27; and suggests an anorectal source?</li><li>4. For patients aged 40-49 with minimal BRBPR and no increased risk factors, what is the recommended initial diagnostic test?</li><li>5. What is the recommended frequency for colonoscopy surveillance in average-risk patients over 50 with persistent bleeding from a documented outlet source, in the absence of anemia or symptom changes?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Introduction &amp; Evaluation Guidance</strong></summary>
            <div>
                <ul><li>Evaluation of minimal BRBPR guided by risk of underlying serious pathology.</li><li>Focus: age + other risk factors for serious etiologies.</li><li>Distinguish from: larger blood amounts / blood intermixed w/ stool.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Definition of Minimal BRBPR</strong></summary>
            <div>
                <ul><li>Small amounts of red blood on toilet paper after wiping.</li><li>Few drops of blood in toilet bowl after defecation.</li><li>Small amounts of blood on stool surface.</li><li>NOT: red blood intermixedw/ stool.</li></ul>
                
        <details>
            <summary><strong>Clinical Differentiation</strong></summary>
            <div>
                <ul><li>Minimal BRBPR → lesion near anal canal.</li><li>Melena → upper GI / slow proximal colonic bleeding.</li><li>Maroon stool w/ intermixed BRB → proximal colonic / small intestinal source.</li><li>Perception of stool color varies widely among patients/clinicians.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Etiology Prevalence</strong></summary>
            <div>
                <ul><li>Benign etiologies: common, account for ≥90% of minimal BRBPR episodes.</li><li>True proportion may be higher: many young people w/ minimal BRBPR never seek care.</li><li>Serious diagnoses: scant rectal bleeding is a common symptom of colorectal cancer.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Epidemiology</strong></summary>
            <div>
                <ul><li>Self-report: ≈15% of adults experience minimal BRBPR.</li><li>May be ↑ common in younger adults: less likely to seek medical consultation.</li></ul>
                
        <details>
            <summary><strong>Study Findings</strong></summary>
            <div>
                <ul><li>Australian study (202 adults, ≥30 yrs): 14% reported blood on toilet paper; 2% reported blood in toilet bowl (prior 6 months).</li><li>43% seldom/never looked @ stool/toilet paper → true frequencies likely ↑.</li><li>Community study (1643 adults, 20-64 yrs): 13% reported ever having blood on wiping.</li><li>Prevalence of any rectal bleeding significantly ↑ in younger people.</li><li>Only 14% w/ any rectal bleeding had seen a physician for bowel problems in prior year.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Etiologies of Minimal BRBPR</strong></summary>
            <div>
                <ul><li>Highly variable; depends on population studied.</li><li>Often difficult to determine specific cause: multiple culpable lesions @ endoscopy.</li><li>Definitive cause: only when lesion actively bleeding is witnessed.</li></ul>
                
        <details>
            <summary><strong>Common Causes</strong></summary>
            <div>
                <ul><li>Hemorrhoids: 27-95% of cases.</li><li>Painless bleeding, usually w/ bowel movement.</li><li>BRB typically coats stool @ end of defecation; may drip into toilet / stain toilet paper.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Anal Fissures</strong></summary>
            <div>
                <ul><li>Often diagnosed from clinical history: tearing pain w/ bowel movements.</li><li>Accompanied by BRB: small amount on toilet paper / stool surface.</li><li>Some patients: itch / perianal skin irritation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Polyps</strong></summary>
            <div>
                <ul><li>Generally asymptomatic; most often detected by colon cancer screening.</li><li>Small adenomas: typically do not bleed.</li><li>Occult bleeding + minimal BRBPR can occur; more likely w/ distal polyps.</li><li>Colorectal neoplasms (mostly adenomas): found in 16% of patients concurrently diagnosed w/ anorectal bleeding source.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Proctitis / Proctosigmoiditis</strong></summary>
            <div>
                <ul><li>Insidious presentation: intermittent rectal bleeding, mucus passage, mild diarrhea (&lt;4 small loose stools/day).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Rectal Ulcers</strong></summary>
            <div>
                <ul><li>Presentation: bleeding, mucus passage, straining during defecation, sense of incomplete evacuation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Cancer</strong></summary>
            <div>
                <ul><li>Majority of symptomatic colorectal cancer patients: hematochezia, abdominal pain, Δ bowel habits.</li><li>Minimal BRBPR from colorectal cancer: likely left-sided lesions.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Diverticulosis</strong></summary>
            <div>
                <ul><li>Common finding on endoscopy in older adults.</li><li>Generally incidental finding in chronic/recurrent minimal BRBPR workup.</li><li>Diverticular bleeding: usually more acute + greater volume.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Clinical Assessment</strong></summary>
            <div>
                <ul><li>Goal: identify patients @ risk for serious bleeding cause → require additional testing.</li><li>Careful clinical assessment: unreliable for determining bleeding site / ruling out significant pathology.</li><li>Example: hemorrhoids do not exclude proximal culprit lesion; may mask early neoplastic lesion.</li></ul>
                
        <details>
            <summary><strong>Assessment Challenges</strong></summary>
            <div>
                <ul><li>Study (145 patients ≥40 yrs, rectal bleeding &lt;6 months): 11/63 patients (PCP predicted anal source) had colonic/rectal source.</li><li>Study (297 patients w/ visible rectal bleeding): 201 underwent sigmoidoscopy + barium enema.</li><li>24% had serious pathology: 13% polyps, 6.5% colon cancer, 4% IBD.</li><li>Among 58 patients &lt;50 yrs: no cancer, but 12% had polyps / IBD.</li><li>Clinical variables + anoscopic findings: unable to identify group of ≥15 patients w/ risk of serious conditions &lt;7%.</li><li>Only ↑ age, shorter bleeding duration, blood mixed w/ stool → associated w/ serious cause.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Screening Overlap</strong></summary>
            <div>
                <ul><li>Many patients w/ minimal BRBPR already have indications for colon cancer screening but are uninvestigated.</li><li>Colonoscopy can be recommended for screening purposes alone in such patients.</li><li>Other patients: history + physical exam + risk assessment (predominantly age) guide need for additional testing.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>History Taking</strong></summary>
            <div>
                <ul><li>Confirm scant rectal bleeding diagnosis.</li><li>Identify worrisome symptoms + historical risk factors.</li></ul>
                
        <details>
            <summary><strong>Bleeding Pattern</strong></summary>
            <div>
                <ul><li>Anorectal source: spots of blood on toilet paper / blood dripping into toilet after defecation.</li><li>Referred to as &#x27;outlet-type bleeding&#x27;.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Associated Symptoms</strong></summary>
            <div>
                <ul><li>Anal pain (during/after defecation): usually anal fissures; also rectal carcinoma / infectious causes (herpes) → not helpful for distinguishing benign vs. serious.</li><li>Recent rectal trauma (medical procedures, anal receptive intercourse): suggests obvious source.</li><li>Systemic symptoms (night sweats, fever, weight loss): suggest malignancy / chronic infection / inflammation.</li><li>Diarrhea (preceding/accompanying blood): suggests colitis.</li><li>Tenesmus: can be present w/ proctitis.</li><li>Nonspecific abdominal pain: indicates process beyond rectum.</li><li>Δ frequency / caliber of stools: suggestive of colonic malignancy.</li><li>Presence of any of these symptoms → further evaluation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Past Medical History</strong></summary>
            <div>
                <ul><li>Previous GI blood loss + investigations.</li><li>Previously resected colon cancer / polyps.</li><li>Inflammatory bowel disease (IBD): ↑ risk of colonic neoplasm.</li><li>Pelvic radiation therapy: radiation proctitis 2-3 years post-therapy.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Age as Risk Factor</strong></summary>
            <div>
                <ul><li>Major risk factor for colorectal cancer.</li><li>Infrequent diagnosis &lt;40 yrs.</li><li>Incidence ↑ significantly between 40-50 yrs; age-specific incidence rates ↑ in each succeeding decade.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Family History</strong></summary>
            <div>
                <ul><li>Detail family history to stratify colorectal cancer risk.</li><li>Include confirmed colorectal cancers, colonic polyps, other malignancies associated w/ familial colon cancer syndromes.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Physical Examination</strong></summary>
            <div>
                <ul><li>Identify possible/definite bleeding sources.</li><li>Find worrisome distal lesions detectable on exam.</li><li>Must include: external inspection of anus + digital rectal examination.</li><li>Patient bearing down: may induce hemorrhoid prolapse / bleeding of surface lesion.</li></ul>
                
        <details>
            <summary><strong>Anoscopy / Proctoscopy</strong></summary>
            <div>
                <ul><li>Office-based anoscopy/proctoscopy: should be carried out in acute minimal BRBPR.</li><li>Simple maneuvers; no bowel prep required.</li><li>Yield highest when performed during bleeding episode.</li><li>Anoscopy: higher sensitivity for hemorrhoid detection than flexible video endoscopy.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Laboratory Testing</strong></summary>
            <div>
                <ul><li>Contributes little info to very low risk patients.</li><li>May prompt more extensive investigation in intermediate risk for colonic neoplasia.</li><li>CBC + ferritin: reasonable preliminary tests for patients &gt;40 yrs / w/ other risk factors (e.g., family history).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Diagnostic Tests</strong></summary>
            <div>
                <ul><li>Colonoscopy / sigmoidoscopy: generally recommended when additional evaluation warranted.</li><li>Barium enema: no role in initial evaluation.</li><li>Insensitive to small neoplasms; cannot identify acutely bleeding lesions; poor evaluation of distal colon/rectum.</li><li>Computed tomographic colonography (CTC): not indicated in initial investigation.</li><li>May be useful in individual cases: colonoscopy incomplete / contraindicated.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Sigmoidoscopy vs. Colonoscopy</strong></summary>
            <div>
                <ul><li>Flexible sigmoidoscopy: investigates distal 60 cm of colon.</li><li>Advantages: can be done w/o sedation (sometimes used); widely available.</li><li>Main disadvantage: potential need for colonoscopy if no bleeding source / distal adenomatous polyp found → two endoscopic procedures.</li></ul>
                
        <details>
            <summary><strong>Colonoscopy</strong></summary>
            <div>
                <ul><li>Definitive tool: evaluating entire colon for neoplastic lesions.</li><li>Sensitive tool: detection of all other lower GI bleeding lesions.</li><li>Requires: full bowel preparation, available facility, often conscious sedation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Concerns w/ Sigmoidoscopy</strong></summary>
            <div>
                <ul><li>Proponents of colonoscopy: concern for proximal lesions out of sigmoidoscope reach.</li><li>Most studies reporting ↑ incidence of proximal neoplasms w/ scant BRBPR: lacked detailed bleeding pattern descriptions; uncontrolled / retrospective data.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Studies Supporting Sigmoidoscopy</strong></summary>
            <div>
                <ul><li>Largest prospective study (4265 patients referred for colonoscopy): 468 scant BRBPR, 299 occult, 57 dark red.</li><li>Excluded: IBD, personal/family history CRC.</li><li>Colonic neoplasms: 18% w/ minimal BRBPR; 7.5% controls.</li><li>Majority of lesions: within sigmoidoscope reach.</li><li>Minimal BRBPR patients: no ↑ risk for proximal lesions vs. controls.</li><li>89 patients ≤40 yrs: 3 cancers, 5 adenomas; no cancers, only 2 adenomas proximal to sigmoidoscope reach.</li><li>Proximal neoplasm risk significantly ↑: occult bleeding (OR 3.1, 95% CI 1.8-5.5) / maroon blood (OR 4.8, 95% CI 2.0-11.5).</li><li>Smaller study (115 patients w/ &#x27;outlet bleeding&#x27;, no other symptoms/risk factors): only 1 adenomatous polyp, no cancers missed by sigmoidoscopy.</li><li>Study (223 adults &lt;50 yrs, nonurgent rectal bleeding): 4 cancers, 22 adenomas detected.</li><li>Only lesions proximal to sigmoidoscope reach: 6 adenomas &lt;8 mm.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Cost-Effectiveness &amp; Guidelines</strong></summary>
            <div>
                <ul><li>One study: sigmoidoscopy as initial investigation for BRB hematochezia not cost-effective (often followed by colonoscopy).</li><li>Excluded patients w/ histories suggestive of outlet bleeding.</li><li>Another study: colonoscopy identified diagnosis in 90% of patients; sigmoidoscopy in &lt;10% (69% abnormal, but 90% required further tests).</li><li>Sigmoidoscopy: recommended as first investigation for BRB hematochezia by some authors for patients up to age 50.</li><li>Acceptable alternative for colorectal cancer screening.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>ASGE Recommendations</strong></summary>
            <div>
                <ul><li>Healthy individuals &lt;40 yrs w/ minimal BRBPR: DRE + sigmoidoscopy may be sufficient.</li><li>Colonoscopy recommended: if anorectal source not found @ initial evaluation; all patients ≥50 yrs; patients w/ other symptoms (iron deficiency anemia), CRC risk factors, or alarm symptoms.</li><li>These are only consensus recommendations specifically addressing scant rectal bleeding.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>European Panel Recommendations</strong></summary>
            <div>
                <ul><li>Colonoscopy inappropriate: patients &lt;50 yrs w/ identified bleeding source.</li><li>Colonoscopy generally appropriate: patients w/ no identified bleeding source.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Author&#x27;s Approach to Age &amp; Screening</strong></summary>
            <div>
                <ul><li>Colonoscopy: test of first choice for patients ≥50 yrs.</li><li>CRC screening for &#x27;average risk&#x27; patients: begins @ age 45 yrs.</li><li>∴ Patients ≥50 yrs w/ scant rectal bleeding: should undergo colonoscopy regardless of identified anorectal pathology.</li><li>Patients ≥45 yrs: colonoscopy may be reasonable if no anorectal source found.</li><li>This age group: ↓ risk of CRC but significant incidence of precancerous adenomatous polyps.</li><li>USPSTF + American Cancer Society: suggest initiating average-risk screening @ age 45.</li><li>Study (screening colonoscopy in 906 patients 40-49 yrs): no cancers; adenomatous polyps in ≈13%; 3.5% had advanced lesions.</li><li>Flexible sigmoidoscopy: alternative first line for unexplained bleeding up to age 50.</li><li>Choice of test in this group: influenced by cost + availability.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Approach to the Patient</strong></summary>
            <div>
                <ul><li>Based on indirect evidence from rectal bleeding studies (not strictly minimal BRBPR) + expert opinion.</li></ul>
                
        <details>
            <summary><strong>Red Flags: Indications for Additional Testing</strong></summary>
            <div>
                <ul><li>Patients w/ minimal BRBPR + following features/risk factors: undergo additional testing regardless of age.</li></ul>
                
        <details>
            <summary><strong>Bleeding Characteristics</strong></summary>
            <div>
                <ul><li>Melena, dark red blood per rectum, postural vital sign abnormalities → evaluate for upper GI pathology first.</li><li>Even if lower GI source possible: more likely proximal vs. distal colonic lesions → colonoscopy after upper GI investigations.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Systemic/Bowel Symptoms</strong></summary>
            <div>
                <ul><li>Symptoms suggestive of malignancy: constitutional symptoms, anemia, Δ frequency/caliber/consistency of stools → colonoscopy.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Occult Blood</strong></summary>
            <div>
                <ul><li>Fecal occult blood positive stools: known mortality benefit from colonoscopy investigation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Family History</strong></summary>
            <div>
                <ul><li>Family histories suggestive of familial polyposis / hereditary nonpolyposis colon cancer syndromes → colonoscopy.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Age-Based Approach</strong></summary>
            <div>
                <ul><li>Age 50 or older: colonoscopy is test of first choice.</li><li>CRC screening recommended for average-risk patients beginning @ age 45.</li><li>∴ Patients ≥50 yrs w/ scant rectal bleeding: undergo colonoscopy regardless of identified anorectal pathology.</li></ul>
                
        <details>
            <summary><strong>Prior Normal Colonoscopy</strong></summary>
            <div>
                <ul><li>Technically adequate normal colonoscopy within previous 2 years: insufficient time to develop clinically important neoplasm.</li><li>More limited investigations (e.g., sigmoidoscopy) can be considered to confirm outlet source.</li><li>Ensure prior colonoscopy: reached cecum w/ good visualization; terminal ileum reached; satisfactory bowel preparation documented.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Ages 40 to 49</strong></summary>
            <div>
                <ul><li>Minimal BRBPR, no ↑ risk for CRC (based on presentation/history): undergo @ least sigmoidoscopy.</li><li>Author&#x27;s suggestion: colonoscopy for most patients, particularly ≥45 yrs, if no bleeding cause identified on sigmoidoscopy.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Age Less Than 40</strong></summary>
            <div>
                <ul><li>Low risk of CRC.</li><li>No further evaluation necessary: if presentation/history do not suggest ↑ cancer risk + potential bleeding source (hemorrhoids/anal fissure) identified on physical exam / anoscopy/proctoscopy.</li><li>If no potential bleeding source identified: sigmoidoscopy / colonoscopy.</li><li>No high-quality data to inform approach; further testing decisions based on shared clinical decision-making.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Persistent Bleeding</strong></summary>
            <div>
                <ul><li>May require different management.</li><li>Some studies: longer bleeding duration associated w/ ↓ risk of cancer.</li><li>Example: risk of cancer higher among patients &gt;50 yrs when bleeding &lt;2 months (18% vs. 6%).</li></ul>
                
        <details>
            <summary><strong>Cautious Strategy (Author&#x27;s Suggestion)</strong></summary>
            <div>
                <ul><li>Absence of definitive data / expert consensus + possibility of concurrent serious pathology.</li><li>Patients who continue to pass blood after identification + definitive management of anorectal lesion: generally undergo colonoscopy @ least once to ensure no additional/concurrent proximal lesion missed.</li><li>Patients w/ recurrent minimal BRBPR: periodically reassessed for any Δ in symptoms / development of new &#x27;red flags&#x27;.</li><li>Patients &gt;50 yrs w/ persistent bleeding from documented outlet source: reassessed @ least yearly for Δ in symptoms / development of anemia / iron deficiency (could prompt repeat colonoscopy).</li><li>Absence of anemia / Δ in symptoms: average-risk patients (colonoscopy screening every 10 years by guidelines) could be considered for closer surveillance w/ colonoscopies as frequently as every 5 years.</li><li>Frequency depends on patient preference + quality of previous colonoscopic evaluations.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Information for Patients</strong></summary>
            <div>
                <ul><li>UpToDate offers &#x27;The Basics&#x27; (5th-6th grade reading level) and &#x27;Beyond the Basics&#x27; (10th-12th grade reading level) patient education materials.</li></ul>
                
        <details>
            <summary><strong>Relevant Basics Topics</strong></summary>
            <div>
                <ul><li>Patient education: Colonoscopy (The Basics).</li><li>Patient education: Bloody stools in adults (The Basics).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Relevant Beyond the Basics Topics</strong></summary>
            <div>
                <ul><li>Patient education: Colonoscopy (Beyond the Basics).</li><li>Patient education: Flexible sigmoidoscopy (Beyond the Basics).</li><li>Patient education: Blood in the stool (rectal bleeding) in adults (Beyond the Basics).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
